Temozolomide in patients with advanced non-small cell lung cancer with and without brain metastases - a phase II study of the EORTC Lung Cancer Group (08965)

By Dziadziuszko R.   Ardizzoni A.   Postmus P.E.   Smit E.F.   Price A.   Debruyne C.   Legrand C.   Giaccone G.   on behalf of the EORTC Lung Cancer Group  

European Journal of Cancer, Vol. 39, Iss. 9, 2003-06 ,pp. : 1271-1276

Elsevier

Access to resources Recommend Favorite

Zoledronic acid treatment in advanced non-small cell lung cancer patients with bone metastases

By Song Zhengbo   Zhang Yiping  

Medical Oncology, Vol. 31, Iss. 4, 2014-04 ,pp. : 1-4

Humana Press, Inc

Access to resources Recommend Favorite

Prognostic factors for patients in postoperative brain metastases from surgically resected non-small cell lung cancer

By Sakamoto Jin   Sonobe Makoto   Kobayashi Masashi   Ishikawa Masashi   Kikuchi Ryutaro   Nakajima Daisuke   Yamada Tetsu   Nakayama Ei   Takahashi Tsuyoshi   Sato Toshihiko   Chen Fengshi   Bando Toru   Date Hiroshi  

International Journal of Clinical Oncology, Vol. 19, Iss. 1, 2014-02 ,pp. : 50-56

Springer Publishing Company

Access to resources Recommend Favorite

Personalized peptide vaccination in patients with refractory non-small cell lung cancer

By                        

International Journal of Oncology, Vol. 40, Iss. 5, 2012-01 ,pp. : 1492-1500

Spandidos Publications

Access to resources Recommend Favorite

Gemictabine plus carboplatin in patients with advanced non-small cell lung cancer

By Park Se   Jeong Seong   Kyung Sun   Lim Young-Hee   An Chang   Lee Sang   Park Jeong   Bang Soo   Cho Eun   Shin Dong   Lee Jae  

Medical Oncology, Vol. 22, Iss. 4, 2005-12 ,pp. : 359-366

Humana Press, Inc

Access to resources Recommend Favorite